They can reduce hepatic steatosis (fat accumulation in the liver), which is a characteristic of non-alcoholic fatty liver disease (NAFLD)
[10] The first amylin analogue to reach the clinic, pramlintide, demonstrated that the pathway could be drugged, but native-style amylin analogues are short-acting and were used as multiple-daily injections, which limited their appeal for weight management
Additionally, some study results also suggest that GLP-1 RAs reduce the occurrence of anxiety, depression, suicidal behaviors, and so on [Reference Tsai, Sung, Chiu, Shih, Tsai and Wu12, Reference Wang, Volkow, Berger, Davis, Kaelber and Xu49, Reference Pozzi, Mazhar, Peeters, Vantaggiato, Nobile, Clementi and Nobile50]
What this means for you Right now, tirzepatide is the only option of the two that you can actually get
Peptide therapy may be considered as part of a provider-guided approach for chronic pain and inflammation support